Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET
PHASE2
This is a phase 2, open-label, randomized study of adjuvant treatment in su...
Status
Recruiting
Location
Dept of Surgical Sciences - Urology, Molinette Hospital, University of Torino
A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE1
This is an open label, non-randomized, Phase I, dose escalation/dose expans...
An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment
N/A
In this observational study, participants receive darolutamide: a treatment...